ABO-402

N/A

Report date: 2025/01/26 18:24:12

Base Information

Drug NameABO-402
Drug Alias NameCFTR gene therapy (Abeona Therapeutics/Case Western Reserve University)adeno associated virus based gene therapy (Abeona Therapeutics/Case Western Reserve University)ABO-402
ClassificationBiologics
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulators
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCase Western Reserve University
China Registration ClassN/A

Develop Information

Active CompaniesCase Western Reserve UniversityAbeona Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A